Merck & Co. MRK shares traded lower on Tuesday, tracking a broader market downturn as major indices slipped into the red. The company said it has commenced a cash tender offer, through a subsidiary, ...

Merck (NYSE:MRK | MRK Price Prediction) delivered its fourth consecutive earnings beat, but shares slipped on the earnings ...

Terns is now a wholly-owned subsidiary of Merck and its stock will no longer be listed or traded on the Nasdaq Global Select ...

Merck (NYSE: MRK), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its famous ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health ...

Okay, I thought Merck got, you know what, Merck reported a really good quarter, and it just happened on a day when people ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the ...

MRK is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of MRK shares has decreased $0.92 since the market last closed. This is a 0.82% ...

Merck once again suffers the mixed optics from the updated FY2026 adjusted EPS guidance, attributed to the IPR&D charges.

Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Turning $10,000 into $50,000 in about five years would require a compound annual growth rate (CAGR) of almost 38%. That's an extremely tough task for any corporation, but can Merck (NYSE: MRK), a ...